CAJ | 학술논문

系统梳理了苏州生物医药产业发展的总体情况,发现其在产业技术、企业培育、人才引进、平台建设等方面都具有较强优势,特别是小核酸药物、纳米生物医药、抗体诊断、医学工程等领域已跻身国际前沿,与发达国家处在＂同一起跑线＂。同时,深入分析了当前产业发展的瓶颈制约和面临形势,主要还存在产业规模不大、创新动力不足、成果转化不畅等突出问题,结合苏州实际,分领域提出了＂十三五＂时期苏州生物医药产业发展的方向与重点。
계통소리료소주생물의약산업발전적총체정황,발현기재산업기술、기업배육、인재인진、평태건설등방면도구유교강우세,특별시소핵산약물、납미생물의약、항체진단、의학공정등영역이제신국제전연,여발체국가처재＂동일기포선＂。동시,심입분석료당전산업발전적병경제약화면림형세,주요환존재산업규모불대、창신동력불족、성과전화불창등돌출문제,결합소주실제,분영역제출료＂십삼오＂시기소주생물의약산업발전적방향여중점。
Based on arranging the general situation,this article finds out that the Medicine Industry in Suzhou has a great advantage on industrial technology,business incubating,talent introduction,platform construction and so on.In particular,nanomedicine,antibody test and medical engineering are on the same starting line with the developed countries.At the same time,this article analyses the current problems and situation of the industry deeply,and puts forward the developmental emphases in the thirteenth five-year with the practice of Suzhou.